Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infection

Pediatric Nephrology

Volumn 30, Issue 1, 2015, Pages 153-165

  Mitchell, Charles D ^a   Chernoff, Miriam C ^b   Seage, George R ^b,c   Purswani, Murli U ^d   Spiegel, Hans M L ^e   Zilleruelo, Gaston ^a   Abitbol, Carolyn ^a   Heckman, Barbara ^f   Ponce, Christopher B ^g   Oleske, James M ^g  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^g RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

HAART; HIV; HIV renal disease; Pediatric; Perinatal

Indexed keywords

INDINAVIR; TENOFOVIR;

ABNORMAL LABORATORY RESULT; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CHRONIC KIDNEY FAILURE; FEMALE; FOLLOW UP; HAZARD RATIO; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEDIATRIC HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL LABORATORY EVENT; RISK; VIRUS LOAD; COHORT ANALYSIS; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; VIROLOGY;

CHILD; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; PROPORTIONAL HAZARDS MODELS; VIRAL LOAD;

EID: 84920988884     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2909-1     Document Type: Article

References (22)

1. Eley B (2008) Metabolic complications of antiretroviral therapy in HIV-infected children. Expert Opin Drug Metab Toxicol 4:37–49
2. Smith R, Chernoff M, Williams PL, Malee KM, Sirois PA, Kammerer B, Wilkins M, Nichols S, Mellins C, Usitalo A, Garvie P, Rutstein R (2012) Pediatric HIV/AIDS cohort study (PHACS) team (2012) impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis 31:592–598
3. Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd, Oleske J, Williams PL (2009) PACTG 219C team (2009) incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. Arch Pediatr Adolesc Med 163:164–171
4. Jao J, Wyatt CM (2010) Antiretroviral medications: adverse effects on the kidney. Adv Chronic Kidney Dis 17:72–82
5. Purswani M, Patel K, Kopp JB, Seage GR 3rd, Chernoff MC, Hazra R, Sieberry GK, Mofenson LM, Scott GB, Van Dyke RB (2012) For the pediatric HIV/AIDS cohort study (2012) Tenofovir treatment duration predicts Proteinuria in a multi-ethnic United States cohort of children and adolescents with perinatal HIV-1 infection. Pediatr Infect Dis 32:495–500
6. Andiman WA, Chernoff MC, Mitchell C, Purswani M, Oleske J, Williams PL, Spiegel H, Gona P, Seage GR 3rd (2009) PACTG iDACS 617 study team (2009) incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors. Pediatr Infect Dis J 28:619–625
7. Brogly S, Williams P, Seage GR 3rd, Oleske JM, Van Dyke R, McIntosh K (2005) Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. J Am Med Assoc 293:2213–2220
8. Ray PE, Xu L, Rakusan T, Liu XH (2004) A 20-year history of childhood HIV-associated nephropathy. Pediatr Nephrol 19:1075–1092
9. Naicker S, Han TM, Fabian J (2006) HIV/AIDS--dominant player in chronic kidney disease. Ethn Dis 16(2):56–60
10. Ramsuran D, Bhimma R, Ramdial PK, Naicker E, Adhikari M, Deonarain J, Sing Y, Naicker T (2012) The spectrum of HIV-related nephropathy in children. Pediatr Nephrol 27:821–827
11. Atta MG (2010) Diagnosis and natural history of HIV-associated nephropathy. Adv Chronic Kidney Dis 17:52–58
12. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD (2004) Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 18:541–546
13. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA (2004) The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66(3):1145–1152
14. Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ, Atta MG (2008) Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 28(3):478–486
15. Garg S, Furlow-Parmly C, Frazier E, Skarbinski J (2013) For the Medical Monitoring Monitoring Project; Centers for Disease Control and Prevention, Atlanta, GA Prevalence of Chronic Kidney Disease Among HIV-infected Adults in Care in the United States Medical Monitoring Project, 2009 (2209) Among HIV-infected adults, factors associated with CKD included older age, female sex, duration of HIV≥10 years, AIDS diagnosis, and recent CD4 count <350 cells/mm3. Abstract #809. Paper presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI), Atlanta, GA, 3–6 March 2013, p 427
16. Purswani MU, Chernoff MC, Mitchell CD, Seage GR 3rd, Zilleruelo G, Abitbol C, Andiman WA, Kaiser KA, Spiegel H, Oleske JM (2012) IMPAACT 219/219C study team (2012) chronic kidney disease associated with perinatal HIV infection in children and adolescents. Pediatr Nephrol 27:981–989
17. Tschudy MM, Arcara KM (eds) (2000) Blood chemistries and body fluids. In: The Harriet Lane handbook: a manual for pediatric house officers, 19 edn. Elsevier Mosby, St. Louis, pp 639–650
18. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
19. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA (2005) Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV medicine association of the infectious diseases society of America. Clin Infect Dis 40:1559–1585
20. Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D’Agati VD, Markowitz GS (2010) Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int 78:1171–1177
21. Ryom L, Mocroft A, Kirk O, Worm S, Kamara D, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD (2013) D:a:D study group (2013) association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis 207:1359–69
22. Bhimma R, Purswani MU, Kala U (2013) Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc 16:18596. doi: 10.7448/IAS.16.1.18596.